First line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study

被引：0
|
作者：
Lo Dico, M. [1 ]
Vasile, E. [1 ]
Tibaldi, C. [1 ]
Antonuzzo, A. [2 ]
Di Marsico, R. [3 ]
Tartarelli, G. [4 ]
Fabbri, A. [5 ]
Mazzoni, E.
Andreuccetti, M.
D'Alessandro, M. [6 ]
Nacci, A. [7 ]
Falcone, A. [8 ]
机构：
[1] Civil Hosp, Div Med Oncol, Livorno, Italy
[2] Civil Hosp, Div Med Oncol, Piombino, Italy
[3] Civil Hosp, Div Med Oncol, Cencina, Italy
[4] Civil Hosp, Div Med Oncol, Viareggio, Italy
[5] Civil Hosp, Div Pneumol, Pistola, Italy
[6] Civil Hosp, Div Med Oncol, Empoli, Italy
[7] Santa Chiara Hosp, Div Med Oncol, Pisa, Italy
[8] Univ Pisa, ITT, Tumori, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [21] Biweekly docetaxel and gemcitabine as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Gaspar, E.
    Firvida, J.
    Amenedo, M.
    Orts, D.
    Salgado, M.
    LLorca, C.
    Ramos, M.
    Perez, E.
    Cervera, J.
    Abal, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] A phase II study of oxaliplatin and docetaxel in patients with advanced non-small-cell lung cancer (NSCLC)
    Raez, L
    Santos, E
    Rocha-Lima, C
    Roman, E
    Kumar, P
    Farfan, N
    Decesare, T
    Lopes, G
    Rosado, M
    Wu, J
    [J]. LUNG CANCER, 2005, 49 : S265 - S265
  • [23] A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer
    Francesco Grossi
    Filippo de Marinis
    Vittorio Gebbia
    Ferdinando Riccardi
    Orazio Caffo
    Teresa Gamucci
    Francesco Ferraù
    Mario Nardi
    Luca Moscetti
    Luca Boni
    Davide Dondi
    Enzo Galligioni
    [J]. Cancer Chemotherapy and Pharmacology, 2012, 69 : 369 - 375
  • [24] Phase II Study: Weekly Docetaxel as First Line Chemotherapy for Elderly Patients with Squamous-Cell Non-Small-Cell Lung Cancer
    Lee, S. Y.
    Choi, J. H.
    Chung, S. M.
    Oh, J. Y.
    Lee, Y. S.
    Min, K. H.
    Hur, G. Y.
    Shim, J. J.
    Kang, K. H.
    Lee, H. K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2081 - S2082
  • [25] A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer
    Grossi, Francesco
    de Marinis, Filippo
    Gebbia, Vittorio
    Riccardi, Ferdinando
    Caffo, Orazio
    Gamucci, Teresa
    Ferrau, Francesco
    Nardi, Mario
    Moscetti, Luca
    Boni, Luca
    Dondi, Davide
    Galligioni, Enzo
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 369 - 375
  • [26] Biweekly administration of docetaxel and gemcitabine for elderly patients with advanced non-small cell lung cancer: A phase II study
    Syrigos, K. N.
    Karapanagiotou, E.
    Charpidou, A.
    Dilana, K.
    Dannos, I.
    Dionellis, G.
    Rigopoulou, A.
    Georgatou, N.
    Roussos, C.
    [J]. JOURNAL OF CHEMOTHERAPY, 2007, 19 (04) : 438 - 443
  • [27] A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study
    Masahiro Tabata
    Toshiyuki Kozuki
    Hiroshi Ueoka
    Katsuyuki Kiura
    Shingo Harita
    Atsuhiko Tada
    Takuo Shibayama
    Nagio Takigawa
    Toshiro Yonei
    Kenichi Gemba
    Yoshihiko Segawa
    Daizo Kishino
    Shinya Tada
    Shunkichi Hiraki
    Mitsune Tanimoto
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 53 - 59
  • [28] A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study
    Tabata, Masahiro
    Kozuki, Toshiyuki
    Ueoka, Hiroshi
    Kiura, Katsuyuki
    Harita, Shingo
    Tada, Atsuhiko
    Shibayama, Takuo
    Takigawa, Nagio
    Yonei, Toshiro
    Gemba, Kenichi
    Segawa, Yoshihiko
    Kishino, Daizo
    Tada, Shinya
    Hiraki, Shunkichi
    Tanimoto, Mitsune
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 53 - 59
  • [29] First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: A multicenter phase II study
    Georgoulias, V
    Androulakis, N
    Dimopoulos, AM
    Kourousis, C
    Kakolyris, S
    Papadakis, E
    Apostolopoulou, F
    Papadimitriou, C
    Vossos, A
    Agelidou, M
    Heras, P
    Tzannes, S
    Vlachonicolis, J
    Mavromanolakis, E
    Hatzidaki, D
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (03) : 331 - 334
  • [30] Phase II study of gemcitabine-vinorelbine followed by docetaxel in elderly patients with advanced non-small cell lung cancer
    José-Luis, F
    Gaspar, E
    Sergio, V
    Eva, P
    Cristina, L
    Luis, L
    Margarita, A
    Carlos, G
    Mercedes, S
    José-Ramón, M
    [J]. LUNG CANCER, 2005, 49 : S249 - S249
12345